NCT02280421View on ClinicalTrials.gov

Drug-Drug Interaction Study: ASP2151 and Ciclosporin

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Healthy
Interventions
DRUG

ASP2151 400mg + 100mg ciclosporin

DRUG

ASP2151 1200mg + 100mg ciclosporin

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research Ltd, London

All Listed Sponsors
lead

Maruho Europe Limited

INDUSTRY

NCT02280421 - Drug-Drug Interaction Study: ASP2151 and Ciclosporin | Biotech Hunter | Biotech Hunter